Postoperative adjuvant transarterial (chemo)embolisation after liver resection for hepatocellular carcinoma

To evaluate systematically the available literature of randomised clinical trials regarding the benefits and harms of transarterial (chemo)embolisation as a postoperative adjuvant treatment in people who have undergone hepatectomy for hepatocellular carcinoma.

This is a protocol.

Share/Save